ReviewMicroorganisms2021
Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 22 citations in OpenAlex.
- Longitudinal surveillance of antibiotic resistance and virulence evolution inMicrobiology spectrum · 2026Article
- Wastewater reuse for production of plant-based foods: does spore-formingApplied and environmental microbiology · 2026Review
- Comparison of Phenotypic and Genotypic Antimicrobial Resistances in BovineAntibiotics (Basel, Switzerland) · 2026Article
- The Ambivalent Nature ofToxins · 2025Review
- History and Evolution of the HypervirulentMicroorganisms · 2025Review
- Phenotypic and genotypic antimicrobial resistance profiles of clinical Clostridioides difficile isolates collected from private and public health settings in South Africa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Mobilome of Environmental Isolates ofAntibiotics (Basel, Switzerland) · 2025Article
- Article
- Molecular Epidemiology ofAntibiotics (Basel, Switzerland) · 2025Article
- Antimicrobial resistance ofOne health (Amsterdam, Netherlands) · 2024Article
- Comparative genomics of zoonotic pathogen3 Biotech · 2024Article
- Comparative genome analyses of clinical and non-clinicalFrontiers in microbiology · 2024Article
- Prevalence, Antimicrobial Resistance and Toxin-Encoding Genes ofAntibiotics (Basel, Switzerland) · 2023Article
- Antibiotic Susceptibility, Resistance Gene Determinants and Corresponding Genomic Regions inMicroorganisms · 2022Article
- Antibiotic Resistance Profile of RT 027/176 Versus OtherPathogens (Basel, Switzerland) · 2022Article
- Review
- A species-wide genetic atlas of antimicrobial resistance inMicrobial genomics · 2021Article
- Complete Genome Sequencing and Comparative Phenotypic Analysis Reveal the Discrepancy BetweenFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present paper is divided into two parts. The first part focuses on the role of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.